Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2016

View Archived Issues

GeoVax Labs receives award from NIH for HIV vaccine program for Africa

Takeda initiates first-in-human study of TAK-041

Cancer Genetics offers Ventana PD-L1 assay as complementary diagnostic for Tecentriq

HXP-124 as a novel antifungal agent for the treatment for onychomycosis

Novel ARF6 inhibitors with robust in vivo efficacy

Ampio announces results from phase III PIVOT clinical trial

Galderma Research & Development patents retinoid RORgammaT inverse agonists

Laboratorios del Dr. Esteve discloses dual sigma1 and mu-opioid receptor ligands

PharmNovo describes delta-opioid agonists

Morphic Therapeutic completes series A financing to develop next-generation integrin therapies

Janssen Pharmaceutica develops BACE1 and/or BACE2 inhibitors

Gilead Sciences presents FXR agonists

Regen Biopharma enters deal with Eli lilly

New class of small molecules enhances oncolytic virus replication

Eli Lilly initiates phase I trial of LY-3300054 in advanced refractory solid tumors

PsiOxus, BMS to evaluate enadenotucirev plus nivolumab

Array BioPharma submits NDA for binimetinib for advanced NRAS-mutant melanoma

AstraZeneca and Leo Pharma announce licensing agreements for tralokinumab and brodalumab

Sprint Bioscience partners with Karolinska research team in AML

Takeda Pharmaceuticals begins collaboration with Exosome Diagnostics

Targovax initiates phase Ib/II trial of ONCOS-102 in malignant pleural mesothelioma

GS-9883 found to reduce HIV-1 RNA in clinical trial

Gedeon Richter announces acquisition of Finox

Akers Biosciences completes trial of PIFA/Chlamydia Rapid Assay

Phase II study of Shire's SHP-607 misses primary endpoint

Galmed Pharmaceuticals enters collaboration with Yeda Research and Development

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...